RNASET2 and cancer: Indeed, two independent xenograft-based experimental models of human ovarian carcinoma clearly showed the occurrence of a marked RNASET2-mediated in vivo tumor suppressive role, which was apparently based on the ability of cancer cells-derived RNASET2 protein to recruit M1 macrophages within the TME [1,2].